Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04066231Not ApplicableTerminated

ANTERO-4: VIPUN Gastric Monitoring System in an Erythromycin Model

Role: lead

NCT03512145Not ApplicableCompleted

Clinical Evaluation of the VIPUN Balloon Catheter 0.2 in Critically Ill Patients

Role: lead

NCT03664570Not ApplicableCompleted

Enteral Nutrition Infusion Rate and Gastric Function

Role: lead

NCT03500887Not ApplicableCompleted

Monitoring Stomach Function With an Intragastric Balloon - a Pilot

Role: lead

NCT03441230Not ApplicableCompleted

Determination of the Characteristics of Isometric Gastric Motility Measurement in Healthy Volunteers

Role: lead

NCT02736734Phase 4Completed

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers

Role: lead

All 6 trials loaded